Targeting cAMP Signaling for the Treatment of Inflammatory Diseases of the Skin

Interprets the complexity of cAMP biology and the translational impact of PDE4 inhibition as it relates to chronic inflammatory skin diseases. Learn why targeting this pathway is clinically meaningful but also where more work is needed to improve outcomes.

Presenter: Dr. Jon Zippin, Assistant Attending Dermatologist and Assistant Professor of Dermatology at Weill Medical College of Cornell

Thank you to Celgene and Pfizer for their support of and exhibition at the live presentation.